Legend Biotech Corp at JPMorgan Healthcare Conference (Virtual) Transcript
All right. Good afternoon, everyone, from the Virtual JPMorgan Healthcare Conference. My name is Cory Kasimov, and it's my pleasure to introduce our next company, Legend Biotech; and Ying Huang, the company's CEO and CFO. (Operator Instructions).
So with that, Ying, thanks for being here, and let me turn things over to you.
Great. Thank you, Cory, and thank you for JPMorgan for inviting Legend for this presentation. And first and foremost, I'd like to welcome all of you on behalf of our colleagues across the world, and we hope you're healthy and safe, and your new year is off to a great start. Today, I'll talk about our differentiated technology platform, our R&D capabilities, our global manufacturing strategy and also the expertise that provide Legend with the ability to deliver potentially innovative and impactful cell therapies to patients.
With that, can we go to the next slide, Slide
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
